Gyre Therapeutics, Inc. GYRE Business Segments
| FY'25 | FY'24 | ||
|---|---|---|---|
| Revenue by Business | |||
| Gyre Pharmaceuticals | $116.59M+10.2% | $105.76M-6.8% | |
| Revenue (Gross) by Product | |||
| Contiva | $5.52M— | —— | |
| Square Meter Area For Laboratory Center Under Lease by Geography | |||
| Nanjing | 280— | —— | |
| Shanghai | 896— | —— | |
| Zhengzhou | 720— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Gyre Therapeutics, Inc. break its business down?
- Gyre Therapeutics, Inc. (GYRE) reports revenue by business across 3 parts — All Other Segments, Gyre Pharmaceuticals and Gyre. Each is extracted from the segment footnotes and tracked over time.
- Where does Gyre Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Gyre Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
